Parasite motility

Parasite motility" is a term describing the diverse molecular and cellular mechanisms by which protozoan parasites move and invade host tissues. In apicomplexan parasites (such as Toxoplasma gondii and Plasmodium spp.), motility is powered by a unique actomyosin motor complex known as the "glideosome," which drives gliding movement required for tissue migration, cell invasion, and egress from host cells[1][7]. Key components include unconventional class XIV myosins (e.g., TgMyoA), various glideosome-associated proteins (GAP40, GAP45, GAP50), actin filaments, capping proteins, surface adhesins, and regulatory factors like calcium-dependent protein kinases[1][4][2][7]. Other unrelated parasites, such as trypanosomes, use completely different machinery, including flagella and associated structures[5]. Because "parasite motility" represents a broad, process-level phenomenon rather than a specific molecule or protein, it is not a canonical drug target or molecular entry in pharmacology, and thus the entry is considered incorrect as a "target" in usual drug discovery or molecular biology frameworks. If you need information on a specific protein, enzyme, or molecular complex driving motility (for example, "Class XIV myosin (TgMyoA)" or "Glideosome-associated connector (GAC) protein"), a new and more precise canonical target entry should be created for that entity.